Leslie Wubbel, SaaS Product Manager at LabVantage, shares how the LabVantage cloud-based Laboratory Information Management ...

The speakers highlight emerging trends in GLP-1 therapy, including personalized dosing, weight maintenance, combination ...

Diazonium chemistry offers a stable alternative for silica modification, creating a polymeric-like layer with enhanced hydrolytic stability.

Andrew Anderson, VP of innovation and informatics strategy at ACD/Labs, talks about how the scientific method is being redefined and the role the AI-digital-physical DMTA cycle plays.

Judith Hey-Hadavi and Nicole Snow explore GLP-1 drug shortages, the safety and regulation of compounded alternatives, and ...

Judith Hey-Hadavi and Nicole Snow discuss GLP-1 receptor agonists, emphasizing personalized dosing, side effect management, ...

Judith Hey-Hadavi and Nicole Snow discuss staying current on GLP-1 research and managing therapy side effects to support patient outcomes. In this episode, Judith Hey-Hadavi, vice president of Medical ...

In the second episode of our GLP-1 Therapy Insights series, experts Judith Hey-Hadavi from Worldwide Clinical Trials and ...

IQ Consortium experts explain how advanced chromatographic and analytical strategies are improving the bioanalysis, ...

Researchers investigating the role of cholesterol metabolism disorders in the etiopathogenesis of autism spectrum disorder ...

RNA-based therapeutics face challenges in bioanalysis, with experts recommending strategies to improve LC–MS performance and standardize ADME and DMPK practices. GLP-1 therapies require careful ...

Researchers profiled and compared metabolites in drought-tolerant and drought-susceptible sweet potato cultivars under water-deficient conditions. Leaf samples were collected and analyzed for ...